Table 3.

Odds ratios of sarcopenia and related factors for the prevalence of metabolic syndrome

	Model 1			Model 2
	OR (95% CI)	p		OR (95% CI)	p
Normal (n = 235)	Ref	—		Ref	—
aLMS only (n = 52)	0.84 (0.44–1.59)	0.589		0.83 (0.43–1.58)	0.569
aLMM only (n = 45)	0.28 (0.13–0.60)	<0.001		0.28 (0.13–0.60)	<0.001
Sarcopenia, defined by aLMS and aLMM (n = 39)	0.62 (0.29–1.33)	0.22		0.63 (0.29–1.37)	0.244
Non-sarcopenia (n = 332)	Ref	—		Ref	—
Sarcopenia (n = 39)	0.78 (0.37–1.63)	0.504		0.79 (0.38–1.67)	0.541

	Model 1			Model 2
	OR (95% CI)	p		OR (95% CI)	p
Normal (n = 164)	Ref	—		Ref	—
rLMS only (n = 122)	2.00 (1.20–3.34)	0.008		2.02 (1.20–3.38)	0.008
rLMM only (n = 20)	6.87 (2.11–22.4)	0.001		7.02 (2.14–23.0)	<0.001
Sarcopenia, defined by rLMS and rLMM (n = 65)	30.3 (11.1–82.3)	<0.001		31.2 (11.4–85.6)	<0.001
Non-sarcopenia (n = 306)	Ref	—		Ref	—
Sarcopenia (n = 65)	20.3 (7.72–53.2)	<0.001		20.6 (7.81–54.3)	<0.001

aLMM, absolute low muscle mass; aLMS absolute low muscle strength; rLMM, relative low muscle mass; rLMS, relative low muscle strength. Model 1: Adjusted for age and sex. Model 2: Adjusted for age, sex, smoking, exercise, and alcohol intake.